These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 10249123)
1. Third-party reimbursement: new concepts and contemporary issues. Paul SH; McEvilla JD Med Mark Media; 1980 Oct; 15(10):58-61, 64-70. PubMed ID: 10249123 [No Abstract] [Full Text] [Related]
2. A fee for the service of pharmacy: the time has come. Tanner DJ Hosp Pharm; 1978 Dec; 13(12):692-3, 696. PubMed ID: 10239821 [No Abstract] [Full Text] [Related]
3. Economics of hospital pharmacy practice. I. Third-party reimbursement. Zellmer WA Am J Hosp Pharm; 1979 Feb; 36(2):169. PubMed ID: 420204 [No Abstract] [Full Text] [Related]
4. Capitation reimbursement for pharmacy services: a dissenting view. Gosselin RA Med Mark Media; 1980 Oct; 15(10):51-6. PubMed ID: 10249122 [No Abstract] [Full Text] [Related]
5. Health Care Financing Administration: Pharmaceutical Reimbursement Board; final maximum allowable cost determinations. Fed Regist; 1979 Aug; 44(169):50651-6. PubMed ID: 10297564 [No Abstract] [Full Text] [Related]
6. Capitation payment for pharmacy services: are we ready? Berger BA Med Mark Media; 1980 Oct; 15(10):33-6. PubMed ID: 10249120 [No Abstract] [Full Text] [Related]
8. The tripartite reimbursement incentive model: a new method to eliminate the discounting of the copayment charge. Paul SH Med Mark Media; 1981 Mar; 16(3):35-9. PubMed ID: 10298125 [No Abstract] [Full Text] [Related]
9. Competitive incentive program. Analysis and proposal. Stone J Am Pharm; 1986 Jul; NS26(7):45-9. PubMed ID: 3529904 [No Abstract] [Full Text] [Related]
10. Can health care costs be contained? Yes, says one third party fiscal intermediary. Kaplan SX Empl Benefits J; 1978; 3(4):10-3, 15. PubMed ID: 10294880 [No Abstract] [Full Text] [Related]
11. Perspectives. Medicare doc pay change, big Part B premium hike on the way. Med Health; 2004 Mar; 58(13):1, 7-8. PubMed ID: 15088495 [No Abstract] [Full Text] [Related]
13. Reimbursement of pharmaceuticals in New Zealand: comments on PHARMAC's processes. Swinburn B; Milne RJ; Richards M; Begg E; Foote S; Jackson R N Z Med J; 2000 Oct; 113(1119):425-8. PubMed ID: 11127362 [No Abstract] [Full Text] [Related]
14. The cost of medicine. Silk AD West J Med; 1990 Jan; 152(1):75-6. PubMed ID: 2309481 [No Abstract] [Full Text] [Related]
16. Potential impact of prepayment on Medicaid drug costs. Yesalls CE; Norwood GJ; Lipson DP Contemp Pharm Pract; 1979; 2(2):87-94. PubMed ID: 10297462 [No Abstract] [Full Text] [Related]
17. Payers need to streamline Part D turnaround time to head off potential regulatory changes. Med Health; 2006 Apr; 60(15):1-2. PubMed ID: 16623183 [No Abstract] [Full Text] [Related]